In general, doctors must obtain a patient's consent to treatment before delivering the treatment. Most of the legal cases claiming negligence in treatment relate to surgical procedures but the same principles hold true for non-invasive or medical treatments. Some medical treatments, such as antipsychotic drugs, may have long-term side-effects. A doctor may have to pay compensation to a patient who suffers adverse effects from treatment which was delivered negligently or if the doctor has not given sufficient information to the patient who then suffers the adverse event of which they were not warned was a possibility.
Get full access to this article
View all access options for this article.
References
1.
Department of Health. Code of Practice Mental Health Act 1983. London: Department of Health, 2008
2.
3.
4.
5.
General Medical Council. Consent: patients and doctors making decisions together. London: GMC, 2008
6.
7.
FosterC. It should be, therefore it is. New Law Journal2004; 154: 1644–5
WheatK. Progress of the prudent patient: consent after Chester v Afshar. Anaesthesia2005; 60: 3, 217–19
12.
SamantaJ, DunfordR, SamantaA. Chester v Afshar: implications for clinical negligence. Health Care Risk Report2005; 11: 3, 22–3
13.
GreenS. Coherence of medical negligence cases: a game of doctors and purses. Med Law Rev2006; 14: 1–21
14.
MeadJ. Healthcare and Law Digest. Clinical Risk2007; 13: 3, 123–4
15.
WoernerMG, KaneJM, LiebermanJA, The prevalence of tardive dyskinesia. J Clin Psychopharmacol1994; 11: 34–42
16.
KaneJM, WoernerM, WeinholdP, Incidence of tardive dyskinesia: five-year data from a prospective study. Psychopharmacol Bull1984; 20: 387–9
17.
MorgansternH, GlazerWM. Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study. Arch Gen Psychiatry1993; 50: 723–33
18.
Cunningham OwensDG, JohnstoneEC, FrithCD. Spontaneous involuntary disorders of movement. Arch Gen Psychiatry1982; 39: 452–61
19.
YoussefHA, WaddingtonJL. Morbidity and mortality in tardive dyskinesia: associations in chronic schizophrenia. Acta Psychiatr Scand1987; 75: 74–7
20.
BallesterosJ, Gonzalez-PintoA, BulbenaA. Tardive dyskinesia associated with higher mortality in psychiatric patients: results of a meta-analysis of seven independent studies. J Clin Psychopharmacol2000; 20: 188–94
21.
CorrellCU, LeuchtS, KaneJM. Lower risk for tardive dyskinesia associated with second generation antipsychotics: a systematic review of 1–year studies. Am J Psychiatry2004; 161: 414–25
22.
LeuchtS, WahlbeckK, HamannJ, KisslingW. New generation antipsychotics versus low potency conventional antipsychotics: a systematic review and meta-analysis. Lancet2003; 361: 1581–9
23.
TarsyD, BaldessariniRJ. Epidermiology of tardive dyskinesia: is risk declining with modern antipsychotics?Mov Disord2006; 21: 589–98
24.
Negligent prescribing of long-term antipsychotic over 12 years. Clinical Risk2007; 13: 78–9
25.
MiyamotoS, DuncanGE, MarxCE, Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry2005; 10: 79–104
